A weaker but still high agreement (Kappa >0.55, LCL ≥0.44) was also observed between LPS-specific IgA-and IgG-ALS responders and IgA- and IgG-ASC and serum responders. Here, CD79A is linked to amyotrophic lateral sclerosis.